Thus, the results found in U-87 MG cells treated with TGF-β1 should be reproduced in other glioma cell lines with different aggressiveness and phenotypes to support the oncogenic features of PIMT isoform I in glioma cells. This evidence concerns the gene TGFB1 and central nervous system cancer.